Arcellx · 12 hours ago
QC Associate / Specialist (EM)
Arcellx is a public, clinical-stage biotechnology company focused on innovating cell therapies for cancer and other incurable diseases. They are seeking a QC Associate/Specialist to execute GMP-compliant environmental monitoring, manage lab equipment, and support QC data tracking.
BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Responsibilities
Execute GMP-compliant environmental monitoring of cleanrooms by performing non-viable and viable particulate sampling on a routine basis
Perform growth promotion to qualify media
Contribute to reviewing SOPs, forms, and logbooks related to environmental monitoring and microbiological methods
Governing the upkeep, calibration, and preventive maintenance of lab equipment and instruments
Manage inventory of environmental monitoring samples, lab supplies and materials
Support tracking and trending of QC data
Qualification
Required
BS or MS in biological sciences or a related field
2+ years of pharmaceutical of biotechnology industry experience, including experience in cell therapy or microbiology. Candidates at the specialist level will require more experience
Previous experience performing environmental monitoring in a cleanroom
Excellent written and oral communication skills
Benefits
100% coverage for medical, dental and vision for team members and dependents
Unlimited vacation
A 3-day weekend every month
Fully-paid parental leave for up to 6 months
Tuition reimbursement
401k employer contribution
And more
Company
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
H1B Sponsorship
Arcellx has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (4)
2022 (2)
Funding
Current Stage
Public CompanyTotal Funding
$622MKey Investors
Kite Pharma
2023-11-15Post Ipo Equity· $200M
2022-12-09Post Ipo Equity· $100M
2022-06-15Post Ipo Equity· $112M
Leadership Team
Recent News
2025-12-11
2025-12-08
Company data provided by crunchbase